Merck, Pfizer Skin Cancer Drug Receives Breakthrough Status
FDA granted Avelumab* a Breakthrough Therapy designation for the treatment of patients with metastatic Merkel cell carcinoma
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Merck | Merkel Cell Carcinoma | Pfizer | Pharmaceuticals | Skin | Skin Cancer